WA
AXDX

WealthTrust-Arizona’s Accelerate Diagnostics AXDX Stock Holding History

WealthTrust-Arizona’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-20
Closed -$4K – 621
2014
Q3 		$4K Buy
+20
New +$3.89K ﹤0.01% 508

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.44B AUM 24.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

WealthTrust-Arizona's AXDX Position: Q4 2014 in Review

WealthTrust-Arizona sold out of Accelerate Diagnostics (AXDX) in Q4 2014, closing a stake of 20 shares — an estimated $4K sold.

WealthTrust-Arizona first reported a position in AXDX in Q3 2014 and held it in 1 quarter. The position peaked at $4K in Q3 2014. 78 funds tracked by Wall St. Rank hold AXDX as of Q4 2014.

  • WealthTrust-Arizona reported no remaining Accelerate Diagnostics position as of Q4 2014 after selling out during the quarter.
  • WealthTrust-Arizona sold 20 Accelerate Diagnostics shares in Q4 2014, an estimated $4K.
  • WealthTrust-Arizona first reported a position in Accelerate Diagnostics in Q3 2014 and held it in 1 quarter.
  • WealthTrust-Arizona's Accelerate Diagnostics position peaked at $4K in Q3 2014.
  • 78 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2014.

Based on WealthTrust-Arizona's 13F filing for Q4 2014, filed 22 Jan 2015.